ATTROGY

This brand name is authorized in Austria, Estonia, Lithuania.

Active ingredients

The drug ATTROGY contains one active pharmaceutical ingredient (API):

1	Diflunisal UNII 7C546U4DEN - DIFLUNISAL
	Diflunisal is a potent stabiliser of tetrameric transthyretin (TTR), which effectively stabilises the tetramer against dissociation to the TTR monomers which are responsible for amyloidosis pathology.
	Read more about Diflunisal

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ATTROGY Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02BA11	Diflunisal	N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BA Salicylic acid and derivatives
Discover more medicines within N02BA11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	3124718
LT	Valstybinė vaistų kontrolės tarnyba	1104262